acarbose, a novel drug for type II, or non-insulin-dependent, diabetes

Bayer is now launching acarbose, a novel drug for type II, or non-insulin-dependent, diabetes. They're calling it Precose in the U.S...and Prandase in Canada.

Acarbose is an alpha-glucosidase inhibitor. Blocking this enzyme in the intestine slows the breakdown of carbohydrates to glucose. This reduces hyperglycemia...especially after meals.

Acarbose can be used with diet alone...or with other antidiabetic meds.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote